Additional file 1: Table S1. Primary and secondary outcomes of the studies included in the meta-analysis
Mortality due to septic-shock–induced respiratory failure remains high. A recent meta-analysis sugge...
Background: Intravenous immunoglobulin therapy has been pro-posed as an adjuvant treatment for sepsi...
Introduction: The aim of this study was to investigate the kinetics of immunoglobulin M (IgM) during...
Additional file 2: Table S2. Quality Assessment for Randomized Controlled Trials
Additional file 5: Figure S2. Subgroup analysis-severity scores, evaluating survival benefit of intr...
Additional file 4: Figure S1. Subgroup analysis-sepsis vs severe sepsis or septic shock, evaluating ...
Additional file 3: Table S3. Quality Assessment With NewcastleâOttawa Scale for cohort study
Additional file 6: Figure S3. Forest plot for ventilation free days (VFDs) after intravenous IgM-enr...
Abstract Background Sepsis is characterized by a complex immune response. This meta-analysis evaluat...
Additional file 1. Adjustment of analyses for severity and periods of enrollment and subgroup analys...
5Background: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response t...
Background: Patients with hematological disease are 15 times more likely to develop sepsis than the ...
Aim: Additional treatments for sepsis to be administered alongside the standard therapy recommended ...
Sepsis is characterized by a complex immune response. In this study we aimed to provide a review of ...
Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compa...
Mortality due to septic-shock–induced respiratory failure remains high. A recent meta-analysis sugge...
Background: Intravenous immunoglobulin therapy has been pro-posed as an adjuvant treatment for sepsi...
Introduction: The aim of this study was to investigate the kinetics of immunoglobulin M (IgM) during...
Additional file 2: Table S2. Quality Assessment for Randomized Controlled Trials
Additional file 5: Figure S2. Subgroup analysis-severity scores, evaluating survival benefit of intr...
Additional file 4: Figure S1. Subgroup analysis-sepsis vs severe sepsis or septic shock, evaluating ...
Additional file 3: Table S3. Quality Assessment With NewcastleâOttawa Scale for cohort study
Additional file 6: Figure S3. Forest plot for ventilation free days (VFDs) after intravenous IgM-enr...
Abstract Background Sepsis is characterized by a complex immune response. This meta-analysis evaluat...
Additional file 1. Adjustment of analyses for severity and periods of enrollment and subgroup analys...
5Background: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response t...
Background: Patients with hematological disease are 15 times more likely to develop sepsis than the ...
Aim: Additional treatments for sepsis to be administered alongside the standard therapy recommended ...
Sepsis is characterized by a complex immune response. In this study we aimed to provide a review of ...
Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compa...
Mortality due to septic-shock–induced respiratory failure remains high. A recent meta-analysis sugge...
Background: Intravenous immunoglobulin therapy has been pro-posed as an adjuvant treatment for sepsi...
Introduction: The aim of this study was to investigate the kinetics of immunoglobulin M (IgM) during...
DOI
Add to ORKG